Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the completion of the adult dose escalation portion of the STELLAR Phase 1/2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results